Morphosys Ag Revenue per Employee (MOR), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket
 


Morphosys Ag  (NASDAQ: MOR)
 

Morphosys Ag's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Morphosys Ag's Revenue per employee fell on a trailing twelve month basis to $ 522,254, below the company average number of $660,552.
Within the Healthcare sector Employees of 79 other companies have achieved higher revenue per employee. While Morphosys Ag's total ranking has deteriorated compared to the previous quarter from 0 to 846. Morphosys Ag has 511 employees.


What is Sales per Employee Ratio?







MOR Revenue per Employee (Dec 31 2023)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Revenue Change -14.37 % - - - 54.93 %
Sales per Employee (TTM) $ 522,254 609,900 609,900 609,900 609,900
MOR's Total Ranking # 846 # 0 # 0 # 0 # 1039
Seq. Revenue Change - - - - -


Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 43
Healthcare Sector # 80
Overall Market # 846

Revenue per Employee Statistics
High Average Low
$ 845,673 $ 660,552 $ 463,514
(Dec 31 2020)   (Dec 31 2021)



Financial Statements
Morphosys Ag's Revenue MRQ $ 267 Millions Visit MOR's Income Statement
Morphosys Ag's Revenues TTM $ 267 Millions Visit MOR's aggregate revenue growth
What are MOR's Sales? Visit MOR's Sales by Segment




Other Ratios
Morphosys Ag's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
MOR's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for MOR's Competitors
Revenue per Employee for MOR's Suppliers
Revenue per Employee for MOR's Customers

You may also want to know
MOR's Sales Growth Rates MOR's Pe Price to earnings ratio MOR's Receivables Turnover Ratio MOR's Stock Quote
MOR's Net Income Growth Rates MOR's Ps Price to Sales ratio MOR's Sales per Employee MOR's Asset Turnover Ratio
MOR's Net Margin MOR's Pb Price to Book ratio MOR's Financial Strength Ratios MOR's Dividend Payout Ratio
Date modified: 2026-09-02T20:36:52+00:00




Companies with similar Revenue per Employee for 12 months ending Dec 31 2023, within Healthcare Sector Revenue per Employee Revenue 12 months ending Dec 31 2023Number of Employees Dec 31 2023
Acadia Pharmaceuticals Inc   910,322.06 $ 726.437  Million 798 
Editas Medicine Inc   897,965.52 $ 78.123  Million 87 
Molecular Templates Inc   895,161.29 $ 55.500  Million 62 
Cue Health Inc   886,700.00 $ 70.936  Million 80 
Emmaus Life Sciences Inc   886,515.15 $ 29.255  Million 33 
Patterson Companies Inc   863,847.24 $ 6,565.239  Million 7,600 
Carlisle Companies Incorporated  863,050.85 $ 5,092.000  Million 5,900 
Regeneron Pharmaceuticals Inc   851,213.50 $ 13,117.200  Million 15,410 
Entrada Therapeutics Inc   848,769.74 $ 129.013  Million 152 
Y mabs Therapeutics inc   848,190.00 $ 84.819  Million 100 
Scienture Holdings Inc   844,250.78 $ 7.598  Million
Dynavax Technologies Corporation  841,032.73 $ 231.284  Million 275 
Pacira Biosciences inc   814,207.48 $ 674.978  Million 829 
Alkermes Plc   811,417.07 $ 1,663.405  Million 2,050 
Orasure Technologies Inc  809,304.00 $ 404.652  Million 500 
Merck and Co Inc   801,533.33 $ 60,115.000  Million 75,000 
Intercure Ltd   790,117.78 $ 355.553  Million 450 
Pfizer Inc  779,946.67 $ 58,496.000  Million 75,000 
Amicus Therapeutics inc   779,444.23 $ 398.296  Million 511 
Biocryst Pharmaceuticals Inc   761,866.67 $ 331.412  Million 435 
Veru Inc   759,943.00 $ 15.199  Million 20 
Caremax Inc   751,102.00 $ 751.102  Million 1,000 
Biomarin Pharmaceutical Inc  751,079.17 $ 2,419.226  Million 3,221 
Beam Therapeutics Inc   739,156.56 $ 377.709  Million 511 
Kiniksa Pharmaceuticals International Plc  738,412.57 $ 270.259  Million 366 
Galapagos Nv  735,591.45 $ 268.491  Million 365 
Alnylam Pharmaceuticals Inc   731,316.80 $ 1,828.292  Million 2,500 
Hookipa Pharma inc   718,892.86 $ 20.129  Million 28 
Precision Biosciences Inc  716,573.53 $ 48.727  Million 68 
Eton Pharmaceuticals Inc   705,931.82 $ 31.061  Million 44 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.